Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PURE Regenerative Medicine is a healthcare and biotechnology company specializing in advanced regenerative treatments for orthopedic and musculoskeletal conditions. Led by Dr. Joseph Purita, a pioneer in the field, the company focuses on utilizing autologous stem cell therapy, platelet-rich plasma (PRP), and exosome-based treatments to promote tissue healing and reduce inflammation. Their services target a wide range of conditions including osteoarthritis, sports injuries, and chronic joint pain, offering non-surgical alternatives to traditional orthopedic procedures. The company operates as a clinical practice while also engaging in the refinement of regenerative protocols and the education of medical professionals globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PURE Regenerative Medicine.